World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
42
Citations
6951
World Ranking
7658
National Ranking
3292

Overview

Maren Carbon is a researcher affiliated with Zucker Hillside Hospital in the United States. Their work primarily spans the field of Medicine, with a focus on Psychiatry and Mental Health, Clinical Psychology, Speech and Hearing, and Genetics.

Carbon's research addresses several main topics including Bipolar Disorder and Treatment, Schizophrenia Research and Treatment, Child and Adolescent Psychosocial and Emotional Development, Adolescent and Pediatric Healthcare, as well as Genetics and Neurodevelopmental Disorders.

Recent publications by Maren Carbon include the following:

  • Demographic and Clinical Characteristics, Including Subsyndromal Symptoms Across Bipolar-Spectrum Disorders in Adolescents, 2020, Journal of Child and Adolescent Psychopharmacology
  • DSM-5 Attenuated Psychosis Syndrome in Adolescents Hospitalized With Non-psychotic Psychiatric Disorders, 2020, Frontiers in Psychiatry

The venues where Carbon's research has frequently appeared include Frontiers in Psychiatry and the Journal of Child and Adolescent Psychopharmacology.

Collaboration has been a significant aspect of Carbon's work. Frequent co-authors include Gonzalo Salazar de Pablo, Daniel Guinart, Barbara A. Cornblatt, Andrea M. Auther, and Ricardo E. Carrión.

Best Publications

  • Metabolic brain networks associated with cognitive function in Parkinson's disease.

    Chaorui Huang;Paul J. Mattis;Chengke Tang;Chengke Tang;Kenneth Perrine

  • The role of radiotracer imaging in Parkinson disease

    B. Ravina;D. Eidelberg;J. E. Ahlskog;R. L. Albin

  • Cerebellothalamocortical connectivity regulates penetrance in dystonia.

    Miklos Argyelan;Maren Carbon;Martin Niethammer;Aziz M. Uluğ

  • Clinical predictors of therapeutic response to antipsychotics in schizophrenia.

    Maren Carbon;Christoph U Correll

  • Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis.

    Maren Carbon;Cheng-Hsi Hsieh;John M. Kane;Christoph U. Correll

  • Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia

    Maren Carbon;Christoph U. Correll

  • Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysis

    Britta Galling;Alexandra Roldán;René E Nielsen;Jimmi Nielsen

  • Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents.

    Christoph U. Correll;Julie B. Penzner;Umesh H. Parikh;Tahir Mughal

  • Impaired sequence learning in carriers of the DYT1 dystonia mutation.

    Maria-Felice Ghilardi;Maren Carbon;Giulia Silvestri;Vijay Dhawan

  • Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis.

    Maren Carbon;John M. Kane;Stefan Leucht;Christoph U. Correll

  • Abnormal structure-function relationships in hereditary dystonia

    Maren Carbon;David Eidelberg;David Eidelberg

  • Hereditary dystonia as a neurodevelopmental circuit disorder: Evidence from neuroimaging

    Martin Niethammer;Maren Carbon;Maren Carbon;Miklos Argyelan;David Eidelberg;David Eidelberg

  • Regional metabolism in primary torsion dystonia: Effects of penetrance and genotype

    M. Carbon;S. Su;V. Dhawan;D. Raymond

  • Microstructural white matter changes in carriers of the DYT1 gene mutation.

    Maren Carbon;Peter B. Kingsley;Sherwin Su;Gwenn S. Smith

  • Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation

    K. Asanuma;Y. Ma;J. Okulski;V. Dhawan

  • Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism.

    Marina E Emborg;Maren Carbon;James E Holden;Matthew J During

  • Abnormal striatal and thalamic dopamine neurotransmission: Genotype-related features of dystonia.

    M. Carbon;M. Niethammer;S. Peng;D. Raymond

  • Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease.

    Shigeki Hirano;Kotaro Asanuma;Yilong Ma;Chengke Tang

  • Microstructural white matter changes in primary torsion dystonia.

    Maren Carbon;Peter B. Kingsley;Chengke Tang;Susan Bressman

  • Executive processes in Parkinson's disease: FDG-PET and network analysis.

    Catherine Lozza;Jean-Claude Baron;Jean-Claude Baron;David Eidelberg;Marc J. Mentis

Frequent Co-Authors

David Eidelberg
David Eidelberg Feinstein Institute for Medical Research
Yilong Ma
Yilong Ma Feinstein Institute for Medical Research
Maria Felice Ghilardi
Maria Felice Ghilardi City University of New York
Susanne Walitza
Susanne Walitza University of Zurich
Marc J. Mentis
Marc J. Mentis New York University
Claude Ghez
Claude Ghez Columbia University
Celso Arango
Celso Arango Complutense University of Madrid
Jean-Claude Baron
Jean-Claude Baron University of Cambridge
Kathrin Reetz
Kathrin Reetz RWTH Aachen University
Laurie J. Ozelius
Laurie J. Ozelius Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Maren Carbon

Trending Scientists